Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS
Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS
复制标题
DOI：
10.1111/cea.13230
复制
发表时间：
2018-12-01
影响因子：
6.1
通讯作者：
Bousquet, Jean
中科院分区：
文献类型：
--
作者：
Courbis, Anne-Lise;Murray, Ruth Brigid;Bousquet, Jean
背景资料：近年来，过敏性鼻炎（AR）的管理发生了变化，从疾病严重程度的概念转变为疾病控制的概念，AR临床决策支持系统（CDSS）的发布和患者移动的健康（m-health）工具（如过敏日记）的开发。面向医疗保健提供者的过敏日记伴侣应用程序目前正在开发中，将于2018年推出。它结合了AR CDSS，以提供循证治疗建议，将AR管理中的所有关键利益相关者联系起来。目的：制作AR CDSS（e-CDSS）的电子版本，以纳入过敏日记伴侣，描述用于收集必要信息的应用程序界面，以告知e-CDSS，并总结过敏日记伴侣的一些关键功能。方法：制作e-CDSS并将其纳入过敏日记指南的步骤包括：（a）生成治疗管理方案;（B）专家对治疗建议的共识;（c）生成描述所有AR CDSS方案的电子决策算法;（d）将这些算法数字化以形成e-CDSS;及（e）将e-CDSS嵌入应用程序中，以方便用户与e-CDSS接口。结果：AR领域的主要专家同意AR CDSS方法用于AR管理，并同意Allergy Diary Companion提供的具体治疗建议。基于这一共识，开发了决策流程，并使用适用于IOS平板电脑的Titanium Appcelerator（JavaScript）将其编程到过敏日记伴侣中。据我们所知，这是第一次以这种透明和详细的方式描述任何移动健康工具的开发，不仅在应用程序中，而且在提供的管理建议中提供信心。结论：过敏日记伴侣为供应商提供指南和专家认可的AR管理建议。[MASK第32号文件]。
Background: Allergic rhinitis (AR) management has changed in recent years following the switch from the concept of disease severity to the concept of disease control, publication of the AR clinical decision support system (CDSS) and development of mobile health (m-health) tools for patients (eg Allergy Diary). The Allergy Diary Companion app for healthcare providers is currently being developed and will be launched in 2018. It incorporates the AR CDSS to provide evidence-based treatment recommendations, linking all key stakeholders in AR management.Objective: To produce an electronic version of the AR CDSS (e-CDSS) for incorporation into the Allergy Diary Companion, to describe the app interfaces used to collect information necessary to inform the e-CDSS and to summarize some key features of the Allergy Diary Companion.Methods: The steps involved in producing the e-CDSS and incorporating it into the Allergy Diary Companion were (a) generation of treatment management scenarios; (b) expert consensus on treatment recommendations; (c) generation of electronic decisional algorithms to describe all AR CDSS scenarios; (d) digitization of these algorithms to form the e-CDSS; and (e) embedding the e-CDSS into the app to permit easy user e-CDSS interfacing.Results: Key experts in the AR field agreed on the AR CDSS approach to AR management and on specific treatment recommendations provided by Allergy Diary Companion. Based on this consensus, decision processes were developed and programmed into the Allergy Diary Companion using Titanium Appcelerator (JavaScript) for IOS tablets. To our knowledge, this is the first time the development of any m-health tool has been described in this transparent and detailed way, providing confidence, not only in the app, but also in the provided management recommendations.Conclusion: The Allergy Diary Companion for providers provides guideline and expert-endorsed AR management recommendations. [MASK paper No 32].